Wholesale of pharmaceutical and medical goods
ORIFARM NORWAY AS
Revenue 2024
NOK 142.0m
Operating profit
NOK −1.8bn
Equity
NOK 9.3bn
Incorporated
2020
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 142.0m | |
| Total operating costs | 2.0bn | |
| Operating profit (EBIT) | −1.8bn | |
| Net financial items | 11.7bn | |
| Profit for the year | 7.6bn |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 193.4bn | |
| of which current assets | 193.4bn | |
| Equity | 9.3bn | |
| Total liabilities | 184.1bn |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.